Company attributes
Other attributes
Biogen is a United States-based company in the pharmaceutical industry that researches, develops, and delivers therapies for people living with serious neurological and neurodegenerative diseases. It has other locations world wide including Denmark and Switzerland. It has the stated goal of delivering therapies for its patients as well as investing in areas of highest return to deliver long-term value to its stockholders.
The company manufactures therapies and medicines for diseases such as Parkinson's, Spinal Muscular Atrophy, and Multiple Sclerosis. It also researches solutions for other diseases such as Lupus, Epilepsy, and Schizophrenia. Biogen's drug aducanumab is under review by the Federal Drug Administration and has shown evidence of having the capability of reducing medical conditions that can cause Alzheimer's.
In March 2020, Biogen partnered with Vir to research and manufacture therapies for COVID-19. With the antibody development and manufacturing pact made between the two companies, Biogen would play the role of manufacturing and Vir has researched and developed the antibodies.
